101 related articles for article (PubMed ID: 27465621)
21. High-dose chemotherapy and autologous stem cell transplantation in multiple myeloma: a single institution experience at All India Institute of Medical Sciences, New Delhi, using non-cryopreserved peripheral blood stem cells.
Kayal S; Sharma A; Iqbal S; Tejomurtula T; Cyriac SL; Raina V
Clin Lymphoma Myeloma Leuk; 2014 Apr; 14(2):140-7. PubMed ID: 24342104
[TBL] [Abstract][Full Text] [Related]
22. High-dose therapy followed by autologous peripheral-blood stem-cell transplantation for patients with Hodgkin's disease and non-Hodgkin's lymphoma using unprimed and granulocyte colony-stimulating factor-mobilized peripheral-blood stem cells.
Nademanee A; Sniecinski I; Schmidt GM; Dagis AC; O'Donnell MR; Snyder DS; Parker PM; Stein AS; Smith EP; Molina A
J Clin Oncol; 1994 Oct; 12(10):2176-86. PubMed ID: 7523609
[TBL] [Abstract][Full Text] [Related]
23. Long-term storage of peripheral blood stem cells frozen and stored with a conventional liquid nitrogen technique compared with cells frozen and stored in a mechanical freezer.
McCullough J; Haley R; Clay M; Hubel A; Lindgren B; Moroff G
Transfusion; 2010 Apr; 50(4):808-19. PubMed ID: 19912586
[TBL] [Abstract][Full Text] [Related]
24. Fatal cardiac arrhythmia after infusion of dimethyl sulfoxide-cryopreserved hematopoietic stem cells in a patient with severe primary cardiac amyloidosis and end-stage renal failure.
Zenhäusern R; Tobler A; Leoncini L; Hess OM; Ferrari P
Ann Hematol; 2000 Sep; 79(9):523-6. PubMed ID: 11043425
[TBL] [Abstract][Full Text] [Related]
25. Clinical side effects during peripheral blood progenitor cell infusion.
Donmez A; Tombuloglu M; Gungor A; Soyer N; Saydam G; Cagirgan S
Transfus Apher Sci; 2007 Feb; 36(1):95-101. PubMed ID: 17236813
[TBL] [Abstract][Full Text] [Related]
26. Use of different DMSO concentrations for cryopreservation of autologous peripheral blood stem cell grafts does not have any major impact on levels of leukocyte- and platelet-derived soluble mediators.
Akkök CA; Liseth K; Hervig T; Ryningen A; Bruserud Ø; Ersvaer E
Cytotherapy; 2009; 11(6):749-60. PubMed ID: 19878061
[TBL] [Abstract][Full Text] [Related]
27. Autologous peripheral blood stem cell transplantation (PBSCT) mobilized with G-CSF in AML in first complete remission. Role of intensification therapy in outcome.
Martín C; Torres A; León A; Rubio V; Alvarez MA; Herrera C; Jean-Paul E; Correa MA; Rojas R; Campos R; Serrano J; Romero R; Román J; Guzmán JL; Flores R; Falcón M; Martínez F; Gómez P
Bone Marrow Transplant; 1998 Feb; 21(4):375-82. PubMed ID: 9509972
[TBL] [Abstract][Full Text] [Related]
28. Successful cryopreservation of purified autologous CD34+ cells: influence of freezing parameters on cell recovery and engraftment.
Beaujean F; Bourhis JH; Bayle C; Jouault H; Divine M; Rieux C; Janvier M; Le Forestier C; Pico JL
Bone Marrow Transplant; 1998 Dec; 22(11):1091-6. PubMed ID: 9877272
[TBL] [Abstract][Full Text] [Related]
29. Combined submyeloablative and myeloablative dose intense melphalan results in satisfactory responses with acceptable toxicity in patients with multiple myeloma.
Novitzky N; Thomson J; Thomas V; du Toit C; Mohamed Z; McDonald A
Biol Blood Marrow Transplant; 2010 Oct; 16(10):1402-10. PubMed ID: 20385248
[TBL] [Abstract][Full Text] [Related]
30. Early and long-term engraftment after autologous peripheral stem cell transplantation in acute myeloid leukemia patients.
Specchia G; Pastore D; Mestice A; Liso A; Carluccio P; Leo M; Casanova M; Sibilla S; Giannoccaro M; Liso V
Acta Haematol; 2006; 116(4):229-37. PubMed ID: 17119322
[TBL] [Abstract][Full Text] [Related]
31. Hematologic, immunologic reconstitution, and outcome of 342 autologous peripheral blood stem cell transplantations after cryopreservation in a -80°C mechanical freezer and preserved less than 6 months.
Calvet L; Cabrespine A; Boiret-Dupré N; Merlin E; Paillard C; Berger M; Bay JO; Tournilhac O; Halle P
Transfusion; 2013 Mar; 53(3):570-8. PubMed ID: 22804351
[TBL] [Abstract][Full Text] [Related]
32. Clinical toxicity of cryopreserved circulating progenitor cells infusion.
Zambelli A; Poggi G; Da Prada G; Pedrazzoli P; Cuomo A; Miotti D; Perotti C; Preti P; Robustelli della Cuna G
Anticancer Res; 1998; 18(6B):4705-8. PubMed ID: 9891544
[TBL] [Abstract][Full Text] [Related]
33. Transient global amnesia associated with the infusion of DMSO-cryopreserved autologous peripheral blood stem cells.
Otrock ZK; Beydoun A; Barada WM; Masroujeh R; Hourani R; Bazarbachi A
Haematologica; 2008 Mar; 93(3):e36-7. PubMed ID: 18310533
[TBL] [Abstract][Full Text] [Related]
34. [Angioimmunoblastic T-cell lymphoma occurring four months after autologous peripheral blood stem cell transplantation with high-dose chemotherapy for follicular lymphoma].
Miyazaki K; Masuya M; Yamaguchi M; Isaka S; Nakase K; Kobayashi T; Nakamura S; Shiku H
Rinsho Ketsueki; 2005 Sep; 46(9):1065-70. PubMed ID: 16440766
[TBL] [Abstract][Full Text] [Related]
35. High-dose chemotherapy plus non-cryopreserved autologous peripheral blood stem cell transplantation rescue for patients with refractory or relapsed Hodgkin disease.
Mabed M; Shamaa S
Biol Blood Marrow Transplant; 2006 Sep; 12(9):942-8. PubMed ID: 16920560
[TBL] [Abstract][Full Text] [Related]
36. A randomized phase III clinical trial of autologous blood stem cell transplantation comparing cryopreservation using dimethylsulfoxide vs dimethylsulfoxide with hydroxyethylstarch.
Rowley SD; Feng Z; Chen L; Holmberg L; Heimfeld S; MacLeod B; Bensinger WI
Bone Marrow Transplant; 2003 Jun; 31(11):1043-51. PubMed ID: 12774058
[TBL] [Abstract][Full Text] [Related]
37. Myeloablative conditioning in myelofibrosis using i.v. treosulfan and autologous peripheral blood progenitor cell transplantation with high doses of CD34+ cells results in hematologic responses - follow-up of three patients.
Fruehauf S; Buss EC; Topaly J; Kreipe HH; Ho AD
Haematologica; 2005 Feb; 90(2):ECR08. PubMed ID: 15713582
[TBL] [Abstract][Full Text] [Related]
38. Successful treatment of relapsed T-cell non-Hodgkin's lymphoma with allogeneic peripheral blood stem cell transplantation with double conditioning.
Oji Y; Oka Y; Tatekawa T; Soma T; Matsunashi T; Yamagami T; Tsuboi A; Tamaki H; Kim EH; Sugiyama H; Ogawa H
Int J Hematol; 1999 Jun; 69(4):263-7. PubMed ID: 10407585
[TBL] [Abstract][Full Text] [Related]
39. Myeloablative chemotherapy with autologous peripheral blood stem cell transplantation in patients with poor-prognosis solid tumors - Bulgarian experience.
Avramova B; Jordanova M; Michailov G; Konstantinov D; Christosova I; Bobev D
J BUON; 2006; 11(4):433-8. PubMed ID: 17309174
[TBL] [Abstract][Full Text] [Related]
40. Severe respiratory depression after dimethylsulphoxide-containing autologous stem cell infusion in a patient with AL amyloidosis.
Benekli M; Anderson B; Wentling D; Bernstein S; Czuczman M; McCarthy P
Bone Marrow Transplant; 2000 Jun; 25(12):1299-301. PubMed ID: 10871736
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
